HOME >> BIOLOGY >> NEWS
"Berry, berry, berrygood!"

New Orleans -- Red berry fruits -- such as the elderberry, chokeberry and bilberry -- have been used in folk medicine in Europe and North America for centuries. Hippocrates referred to the elderberry tree as his medicine chest while less famous healers have used the fruit as anti-inflammatory, anti-rheumatic, diuretic and laxative agents, as well as for the treatment of dysentery, stomach ailments, scurvy and urinary tract problems.

The berries contain a unique and complex chemical composition and are all rich in flavonoids, polyphenols and anthocynanins. The anthocyanins are responsible for the red, purple and blue pigments of the berries and hold the most promising properties for human health. Since anthocyanins have been shown to be powerful anti-oxidants, scientific reports about their anti-inflammatory, anti-ulcerative, anti-viral, and anti-cancer properties is not surprising, albeit more work needs to be done.

In recent years, the simple chemical nitric oxide (NO) has been shown to play an enormous role in the function of all arteries in health and disease. NO is produced by endothelial cells, which line the inner surface of all blood vessels. NO is a potent relaxing agent of arterial smooth muscle. It plays a major role in keeping the blood pressure of an individual from becoming dangerously high and in preventing blood vessels from spasming. In addition, NO inhibits the development of blood clots and the early processes of atherosclerosis.

Superoxide belongs to a family of reactive chemicals known as oxygen radicals, reactive oxygen species (ROS) or oxidants, as they are commonly referred to in lay literature. These radicals generally promote spasm, blood clot formation and atherosclerosis in arteries. Oxygen radical generation has been shown to be increased in a variety of cardiovascular diseases and also appears to play a detrimental role in cancers, diabetes and inflammatory conditions. Vitamins C and E are known to scavenge or s
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-967-2751
American Physiological Society
22-Apr-2002


Page: 1 2 3 4

Related biology news :

1. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
2. Chemical signals health of brain cells Symposium
3. The birth of reproductive health: A difficult delivery
4. Ventilation in bars, casinos doesnt control health risk for hospitality workers
5. Diabetics face fewer healthy food choices in some urban areas
6. Human health risks in space flight focus of research internships
7. Study shows impact of emotionally healthy fathers when mothers poor mental health affects children
8. Ottawas leadership in biomedical and health research has paid off
9. Oxygen sensing in worms may hold key to healthy blood pressure in humans
10. Make a splash for public health this summer
11. Endurance exercise found to be equally effective as diuretics in improving cardiac health

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Berry berry berrygood

(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/10/2015)... Mass., Feb. 10, 2015  Alere Inc. (NYSE: ... its financial results for the quarter ended December ... Officer and President of Alere said, "We made ... Alere as the global leader in rapid diagnostics ... the Alere Health divestiture in early January enabled ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine” or ... a fraudulent press release disseminated this morning by PR ... Immunovaccine. This press release states that Immunovaccine has entered ... The press release did not originate from Immunovaccine and ... the press release. Please note that all official ...
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... 2015  23andMe, the leading personal genetics company, today ... Privacy Officer and Corporate Counsel. Black brings a strong ... well as health care regulations. As a member of ... for reviewing, updating and enhancing the company,s privacy and ... She joined the company January 5, 2015 and reports ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
Cached News: